Entity
  • Precigen

  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    115 5,385
  • Activities

  • Technologies

  • Entity types

  • Location

    20358 Seneca Meadows Pkwy, Germantown, MD 20876, USA

    Germantown

    United States of America

  • Employees

    Scale: 201-500

    Estimated: 114

  • Engaged corporates

    0
    0 0
  • Added in Motherbase

    1 year, 7 months ago
Description
  • Value proposition

    Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies.

    Precigen: Advancing Medicine with PrecisionTM
    Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

    Gene Therapy and Cell Therapy

  • Home - Precigen

    Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.

  • https://precigen.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Loading...
Loading...
Social network dynamics